JPS6046110B2 - Method for producing 1-(4-isopropylthiophenyl)-2-n-octylaminopropanol - Google Patents
Method for producing 1-(4-isopropylthiophenyl)-2-n-octylaminopropanolInfo
- Publication number
- JPS6046110B2 JPS6046110B2 JP7078577A JP7078577A JPS6046110B2 JP S6046110 B2 JPS6046110 B2 JP S6046110B2 JP 7078577 A JP7078577 A JP 7078577A JP 7078577 A JP7078577 A JP 7078577A JP S6046110 B2 JPS6046110 B2 JP S6046110B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- compound
- isopropylthiophenyl
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- BFCDFTHTSVTWOG-UHFFFAOYSA-N 2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol Chemical compound CCCCCCCCNC(C)C(O)C1=CC=C(SC(C)C)C=C1 BFCDFTHTSVTWOG-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims description 13
- ZJNGCHWVIQXKRC-UHFFFAOYSA-N 1-(octylamino)propan-1-ol Chemical compound CCCCCCCCNC(O)CC ZJNGCHWVIQXKRC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- -1 etc. Substances 0.000 description 23
- 238000000034 method Methods 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 17
- 150000001414 amino alcohols Chemical class 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- 229960000583 acetic acid Drugs 0.000 description 14
- 239000002253 acid Chemical group 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 235000011054 acetic acid Nutrition 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 9
- 150000002148 esters Chemical group 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000003638 chemical reducing agent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910000039 hydrogen halide Inorganic materials 0.000 description 4
- 239000012433 hydrogen halide Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 229910000103 lithium hydride Inorganic materials 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 239000001119 stannous chloride Substances 0.000 description 3
- 235000011150 stannous chloride Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 2
- XQZASYMQJQSIII-UHFFFAOYSA-N 2-amino-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol Chemical compound CC(C)SC1=CC=C(C(O)C(C)N)C=C1 XQZASYMQJQSIII-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 239000012448 Lithium borohydride Substances 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 238000007126 N-alkylation reaction Methods 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 150000002366 halogen compounds Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005283 haloketone group Chemical group 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- LYQJBZLAANNIER-UHFFFAOYSA-N octyl 4-methylbenzenesulfonate Chemical compound CCCCCCCCOS(=O)(=O)C1=CC=C(C)C=C1 LYQJBZLAANNIER-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 150000003459 sulfonic acid esters Chemical class 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- CNDHHGUSRIZDSL-UHFFFAOYSA-N 1-chlorooctane Chemical compound CCCCCCCCCl CNDHHGUSRIZDSL-UHFFFAOYSA-N 0.000 description 1
- UWLHSHAHTBJTBA-UHFFFAOYSA-N 1-iodooctane Chemical compound CCCCCCCCI UWLHSHAHTBJTBA-UHFFFAOYSA-N 0.000 description 1
- BHLLNXPVJAALHN-UHFFFAOYSA-N 2-(octylamino)propan-1-ol Chemical compound CCCCCCCCNC(C)CO BHLLNXPVJAALHN-UHFFFAOYSA-N 0.000 description 1
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- UUXFWHMUNNXFHD-UHFFFAOYSA-N barium azide Chemical compound [Ba+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] UUXFWHMUNNXFHD-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- UFVHXTNXPVSNOB-UHFFFAOYSA-N butyl octyl sulfate Chemical compound CCCCCCCCOS(=O)(=O)OCCCC UFVHXTNXPVSNOB-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- OOZFJMRPUVMHEW-UHFFFAOYSA-N dioctyl sulfate Chemical compound CCCCCCCCOS(=O)(=O)OCCCCCCCC OOZFJMRPUVMHEW-UHFFFAOYSA-N 0.000 description 1
- KTSKBTNGZJPRPD-UHFFFAOYSA-N dioctyl sulfite Chemical compound CCCCCCCCOS(=O)OCCCCCCCC KTSKBTNGZJPRPD-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- PVAWVKKMOVQQRO-UHFFFAOYSA-N ethyl octyl sulfate Chemical compound CCCCCCCCOS(=O)(=O)OCC PVAWVKKMOVQQRO-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- HMNJFAQMJRFJRF-UHFFFAOYSA-N iron(2+) diazide Chemical compound [Fe+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] HMNJFAQMJRFJRF-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- MYTFUEUTZAAMBN-UHFFFAOYSA-N methyl octyl sulfate Chemical compound CCCCCCCCOS(=O)(=O)OC MYTFUEUTZAAMBN-UHFFFAOYSA-N 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- GVMDZMPQYYHMSV-UHFFFAOYSA-N octyl benzenesulfonate Chemical compound CCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVMDZMPQYYHMSV-UHFFFAOYSA-N 0.000 description 1
- GAUNWUGDTRKGQE-UHFFFAOYSA-N octyl ethanesulfonate Chemical compound CCCCCCCCOS(=O)(=O)CC GAUNWUGDTRKGQE-UHFFFAOYSA-N 0.000 description 1
- GRJPLADOIKKOGS-UHFFFAOYSA-N octyl methanesulfonate Chemical compound CCCCCCCCOS(C)(=O)=O GRJPLADOIKKOGS-UHFFFAOYSA-N 0.000 description 1
- TXQBMQNFXYOIPT-UHFFFAOYSA-N octyl nitrate Chemical compound CCCCCCCCO[N+]([O-])=O TXQBMQNFXYOIPT-UHFFFAOYSA-N 0.000 description 1
- ZSGNFZKQTZPONC-UHFFFAOYSA-N octyl octane-1-sulfonate Chemical compound CCCCCCCCOS(=O)(=O)CCCCCCCC ZSGNFZKQTZPONC-UHFFFAOYSA-N 0.000 description 1
- IPHXZCYRFUCJRD-UHFFFAOYSA-N octyl phenyl sulfate Chemical compound C(CCCCCCC)OS(OC1=CC=CC=C1)(=O)=O IPHXZCYRFUCJRD-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- WVPGXJOLGGFBCR-UHFFFAOYSA-N trioctyl phosphate Chemical compound CCCCCCCCOP(=O)(OCCCCCCCC)OCCCCCCCC WVPGXJOLGGFBCR-UHFFFAOYSA-N 0.000 description 1
- 230000004855 vascular circulation Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は1−(4−イソプロピルチオフェニル)−2−
n−オクチルアミノプロパノールの新規製造法に関する
ものであり、さらに詳しくは式(I)〕CH−S H4
H−℃H3
CH3OHNH。DETAILED DESCRIPTION OF THE INVENTION The present invention provides 1-(4-isopropylthiophenyl)-2-
The present invention relates to a new method for producing n-octylaminopropanol, and more specifically, formula (I)] CH-S H4
H-℃H3CH3OHNH.
(I)で示される1−(4−イソプロピルチオフェニル
)−2−アミノプロパノールもしくはその塩と式(■)
CH3(CH。1-(4-isopropylthiophenyl)-2-aminopropanol or its salt represented by (I) and formula (■)
CH3 (CH.
)6CH。X(■)(式中、xはハロゲン原子又は酸の
エステル残基を表わす。)で示される化合物とを反応さ
せることを特徴とする式(■)
〕CH−S H晋H−CH3(m)
CHaOHNH(CH2)7CH3
フで示される1−(4−イソプロピルチオフェニル)−
2−n−オクチルアミノプロパ、ノールもしくはその塩
の製造法に関するものである。)6CH. Formula (■) characterized by reacting with a compound represented by X (■) (in the formula, x represents a halogen atom or an acid ester residue)] ) CHaOHNH(CH2)7CH3 1-(4-isopropylthiophenyl)-
The present invention relates to a method for producing 2-n-octylaminopropa, nol, or a salt thereof.
式(■)のアミノアルコールは特開昭49−13593
5号公報記載の化合物であり、鎮痙作用、末梢血管拡張
作用、及び抗高血圧作用を有し、心筋層の酸素欠乏症に
対し、保護作用を示す。The amino alcohol of formula (■) is disclosed in JP-A-49-13593.
This is a compound described in Publication No. 5, which has antispasmodic, peripheral vasodilatory, and antihypertensive effects, and exhibits a protective effect against anoxia in the myocardium.
又、臨床研究の結果、脳及び末梢血管循環障害、例えば
、間欠性彼行症及びしばしば動脈硬化症を併発する脳血
管性酸素欠乏症に極めて有効である事が認められている
。式(■)のアミノアルコールは隣接する二個の不斉炭
素原子を有するため、工リトロ体、トレオ体の二種の立
体異性体を含み、しかも、夫々の異性体はラセミ体であ
る。In addition, as a result of clinical research, it has been found to be extremely effective for cerebral and peripheral vascular circulation disorders, such as intermittent erectile dysfunction and cerebrovascular anoxia, which is often accompanied by arteriosclerosis. Since the amino alcohol of the formula (■) has two adjacent asymmetric carbon atoms, it contains two stereoisomers, a tritro-isomer and a threo-isomer, and each isomer is a racemate.
これらのラセミ体混合物からは従来の方法により、光学
活性な式(■)のアミノアルコールを得ることができる
。即ち、ラセミ体から光学的に活性な酸、例えば、酒石
酸、ジアセチル酒石酸、タルトラニル酸、ジベンゾイル
酒石酸、ジトルオイル酒石酸等を用いて、ジアステレオ
マーを形成させ、このジアステレオマーの混合物を晶出
、蒸留、あるいはクロマトグラフィーにより分離し、次
いで分離したジアステレオ,マーから、光学活性な塩基
を遊離する。本発明方法により製造される式(■)のア
ミノアルコールは上述の如く、通常の方法で、工リトロ
体、トレオ体、夫々の光学活性化合物に分離し、夫々を
単独で、また二形態以上の混合物として利用できる。Optically active amino alcohols of formula (■) can be obtained from these racemic mixtures by conventional methods. That is, a diastereomer is formed from the racemate using an optically active acid such as tartaric acid, diacetyltartaric acid, tartoranilic acid, dibenzoyltartaric acid, ditoluoyltartaric acid, etc., and a mixture of this diastereomer is crystallized and distilled. Alternatively, the diastereomers are separated by chromatography, and then the optically active base is released from the separated diastereomers. As mentioned above, the amino alcohol of formula (■) produced by the method of the present invention is separated into the optically active compound of the engineered compound, the threo compound, and each optically active compound by a conventional method, and each can be used alone or in two or more forms. Available as a mixture.
この式(■)のアミノアルコールの無毒性の塩、例えば
、塩化水素酸、臭化水素酸、リン酸、硫酸等の無機酸、
または、シユウ酸、乳酸、酒石酸、酢酸、クエン酸、マ
レイン酸等の有機酸の塩−も又、式(■)のアミノアル
コールと同様に重要な医薬特性を有する。Non-toxic salts of amino alcohols of this formula (■), such as inorganic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, etc.
Alternatively, salts of organic acids such as oxalic acid, lactic acid, tartaric acid, acetic acid, citric acid, maleic acid, etc., also have important pharmaceutical properties similar to the amino alcohols of formula (■).
なお、式(■)のアミノアルコールは製薬上使用される
担体とともに、経口または非経口で患者に投与すること
ができる。The amino alcohol of formula (■) can be administered orally or parenterally to a patient together with a pharmaceutically used carrier.
さらに、式(■)のアミノアルコールは単独で、または
同様のまたは異なる活性を有する他の化合物と併用する
事もできる。Furthermore, the amino alcohol of formula (■) can be used alone or in combination with other compounds having similar or different activities.
式(■)のアミノアルコールを合成する方法としては、
例えば特開昭49−1359357号公報に次の反応式
によつて示される方法が開示されている。The method for synthesizing the amino alcohol of formula (■) is as follows:
For example, JP-A-49-1359357 discloses a method represented by the following reaction formula.
しかしながら、それらの方法は、いずれも、アミノ化の
段階で、多種類の副生成物が認められ4・(本発明者等
の追試によると薄層クロマトグラフィーにより、数個の
スポットが存在した)、目的物の精製操作に長時間を要
するという欠点を有している。本発明者らは式(■)で
示される1−(4−イソプロピルチオフェニル)−2−
n−オクチルアミノプロパノールの製造法につぎ鋭意研
究を行なつた結果、副生成物がほとんど認められず好収
率で目的化合物を合成でき、しかも目的生成物の精製を
短時間で簡単に行なうことができる製造法を見出し本発
明を完成するに至つた。However, in all of those methods, many types of by-products were observed in the amination step. However, it has the disadvantage that it takes a long time to purify the target product. The present inventors have discovered that 1-(4-isopropylthiophenyl)-2- represented by formula (■)
As a result of intensive research into the manufacturing method of n-octylaminopropanol, we have found that the target compound can be synthesized in good yield with almost no by-products observed, and that the target product can be easily purified in a short time. The present invention was completed by discovering a manufacturing method that enables this.
本発明者らは、この研究の過程で本発明方法の出発原料
となる新規化合物(1)を見出すと共にその好都合な製
造法をも見出し本発明を完成するに至つた。式(1)の
化合物またはその塩を出発原料とした本発明の方法すな
わちN−アルキル化反応について詳述する。化合物(1
)の塩としては、塩酸塩、臭化水素酸塩、硫酸塩、リン
酸塩、シウ酸塩、乳酸塩、酒石酸塩、酢酸塩、クエン酸
塩、マレイン酸塩などが用いられる。In the course of this research, the present inventors discovered a new compound (1) which is a starting material for the method of the present invention, and also discovered an advantageous method for its production, leading to the completion of the present invention. The method of the present invention, that is, the N-alkylation reaction using the compound of formula (1) or a salt thereof as a starting material will be described in detail. Compound (1
), hydrochloride, hydrobromide, sulfate, phosphate, oxalate, lactate, tartrate, acetate, citrate, maleate, etc. are used.
N−アルキル化反応に於けるアルキル化剤としては、式
(■)で表わされるハロゲン化合物、及び酸のエステル
が用いられる。As the alkylating agent in the N-alkylation reaction, a halogen compound represented by the formula (■) and an acid ester are used.
ハロゲン化合物としては、塩化オクチル、臭化オクチル
、ヨウ化オクチルが挙げられる。Examples of the halogen compound include octyl chloride, octyl bromide, and octyl iodide.
これらは、化合物(1)またはその塩に対し、モル数で
0.5〜5倍(好ましくは0.8〜1.2倍)用いる。
この反応は溶媒を用いてもよく、または無溶媒で行なつ
てもよい。溶媒を用いる場合、好適な溶媒としては、ベ
ンゼン、トルエン、ナフタリン、テトラリン、デカリン
等の炭化水素、メタノール、エタノール、プロパノール
、ブタノール、アミノアルコール、エチレングリコール
、グリセリン等のアルコール、アセトン、メチルエチル
ケトン等のケトン、クロロホルム、クロルベンゼン等の
ハロゲン化炭化水素、酢酸エチル等のエステル、ジオキ
サン、テトラヒドロフラン等のエーテルが挙げられる。These are used in a molar amount of 0.5 to 5 times (preferably 0.8 to 1.2 times) the amount of compound (1) or its salt.
This reaction may be carried out with or without a solvent. When using a solvent, suitable solvents include hydrocarbons such as benzene, toluene, naphthalene, tetralin, and decalin, alcohols such as methanol, ethanol, propanol, butanol, amino alcohol, ethylene glycol, and glycerin, and ketones such as acetone and methyl ethyl ketone. , halogenated hydrocarbons such as chloroform and chlorobenzene, esters such as ethyl acetate, and ethers such as dioxane and tetrahydrofuran.
反応は温度20〜200℃(好ましくは50〜150℃
)、時間1時間〜10時間(好ましくは2時間〜梠時間
)で行なう事ができる。なお、塩化物、臭化物を用いて
アルキル化する場合、式(1)の化合物と等モルのヨウ
化ナトリウムを添加して反応することもできる。エステ
ルとしてはオクチル基を有する、スルホン酸エステル及
び無機酸のエステルが用いられる。The reaction is carried out at a temperature of 20 to 200°C (preferably 50 to 150°C).
), and can be carried out for 1 to 10 hours (preferably 2 to 10 hours). In addition, when alkylating using chloride or bromide, the reaction can also be carried out by adding an equimolar amount of sodium iodide to the compound of formula (1). As the ester, sulfonic acid esters and esters of inorganic acids having an octyl group are used.
スルホン酸エステルは、CH3(CH2)6CH2一0
S02−R″で示され、R″はC1〜10のアルキル基
あるいはC,〜10のアリール基を表わす。Sulfonic acid ester is CH3(CH2)6CH2-0
It is represented by S02-R'', where R'' represents a C1-10 alkyl group or a C,-10 aryl group.
例えば、メタンスルホン酸オクチル、エタンスルホン酸
オクチル、ブタンスルホン酸オクチル、オクタンスルホ
ン酸オクチル、ベンゼンスルホン酸オクチル、p−トル
エンスルホン酸オクチル等が挙げられる。Examples include octyl methanesulfonate, octyl ethanesulfonate, octyl butanesulfonate, octyl octanesulfonate, octyl benzenesulfonate, octyl p-toluenesulfonate, and the like.
無機酸のエステルとしては、CH3(CH2)6CH2
一0S02−0R″で示される硫酸エステル(R″の意
味は上記と同じである。As an ester of an inorganic acid, CH3(CH2)6CH2
Sulfuric ester represented by 10S02-0R'' (the meaning of R'' is the same as above).
)例えばメチルオクチル硫酸、エチルオクチル硫酸、ブ
チルオクチル硫酸、ジオクチル硫酸、フェニルオクチル
硫酸、p−トリルオクチル硫酸が挙げられる。その他ジ
オクチル亜硫酸等の亜硫酸エステル、オルトリン酸トリ
オクチル等のリン酸エステル、硝酸オクチル等の硝酸エ
ステルが挙げられる。) Examples include methyloctyl sulfate, ethyl octyl sulfate, butyloctyl sulfate, dioctyl sulfate, phenyl octyl sulfate, and p-tolyloctyl sulfate. Other examples include sulfite esters such as dioctyl sulfite, phosphate esters such as trioctyl orthophosphate, and nitric esters such as octyl nitrate.
上述の酸のエステル類を用いる場合にも、前述のハロゲ
ン化アルキルを用いる場合と同一の条件で反応を行なう
事ができる。この場合、例えば、カセイソーダ、カセイ
カl八炭酸ソーダ、炭酸カリ、ピリジン、トリエチルア
ミン等の塩基の存在下で反応を行なうのが好ましい。な
お本反応の場合ヨウ化ナトリウムを添加することはない
。以上に示した方法により製造した式(m)のアミノア
ルコールは反応混合物を抽出、晶出、あるいは必要なら
クロマトグラフィーあるいは適当な酸との塩を形成する
ことにより単離することができる。塩として単離する場
合は例えば式(■)のアミノアルコールと適当な酸とを
アルコール等の溶媒中で等モル反応させ、次いで最初の
溶媒(アルコール等)と混和し得るが、塩が不溶性であ
る他の溶媒、例えばジエチルエーテルを添加することに
)より、アミノアルコールのエーテル溶液に酸を添加す
ることにより、あるいは酸のエーテル溶液にアミノアル
コールを添加することにより塩として沈殿させる。Even when using the esters of the above-mentioned acids, the reaction can be carried out under the same conditions as when using the above-mentioned alkyl halides. In this case, the reaction is preferably carried out in the presence of a base such as caustic soda, caustic soda octacarbonate, potassium carbonate, pyridine, or triethylamine. In this reaction, sodium iodide is not added. The amino alcohol of formula (m) prepared by the method described above can be isolated by extraction, crystallization or, if necessary, chromatography of the reaction mixture or by forming a salt with a suitable acid. In the case of isolation as a salt, for example, the amino alcohol of formula (■) and a suitable acid may be reacted in equimolar amounts in a solvent such as alcohol, and then miscible with the initial solvent (alcohol, etc.); however, if the salt is insoluble, It is precipitated as a salt by adding an acid to an ethereal solution of the aminoalcohol (by adding some other solvent, such as diethyl ether), by adding the acid to an ethereal solution of the aminoalcohol, or by adding the aminoalcohol to an ethereal solution of the acid.
塩を形成するための適当な酸としては、例えば5塩化水
素酸、臭化水素酸、硫酸、リン酸、または過塩素酸等の
無機酸、ギ酸、酢酸、プロピオン酸、グリコール酸、乳
酸、クエン酸、コハク酸、アスコルビン酸、フマル酸、
マレイン酸、酒石酸、フェニル酢酸、安息香酸、アント
ラニル酸、Oサリチル酸、メタンスルホン酸、エタンジ
スルホン酸等の有機酸が挙げられる。Suitable acids for forming salts include, for example, inorganic acids such as pentahydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or perchloric acid, formic acid, acetic acid, propionic acid, glycolic acid, lactic acid, citric acid. acids, succinic acid, ascorbic acid, fumaric acid,
Examples include organic acids such as maleic acid, tartaric acid, phenylacetic acid, benzoic acid, anthranilic acid, O-salicylic acid, methanesulfonic acid, and ethanedisulfonic acid.
次に本発明方法の出発原料である式(1)の化合物は次
に示す方法で製造することができる。Next, the compound of formula (1), which is the starting material for the method of the present invention, can be produced by the method shown below.
(式中、Yはハロゲン原子を表わす。)上に図示された
工程をさらに詳しく説明する。(In the formula, Y represents a halogen atom.) The steps illustrated above will be explained in more detail.
1) アジド化合物(■)の合成
アジド化合物は式(■)のα−ハロケトン例えば、α−
ブロムー4−イソプロピルチオプロピオフエノンと金属
アジド化合物とを適当な溶媒中で混合し反応させること
により得られる。1) Synthesis of azide compound (■) The azide compound is an α-haloketone of formula (■), for example, α-
It is obtained by mixing bromo-4-isopropylthiopropiophenone and a metal azide compound in a suitable solvent and reacting the mixture.
金属アジド化合物としては、例えば、ナトリウムアジド
、バリウムアジド、鉄アジド等が挙げられ、その量はハ
ロケトンに対しモル数で0.8〜5倍(好ましくは1.
0〜2.皓)用いる。Examples of the metal azide compound include sodium azide, barium azide, iron azide, etc., and the amount thereof is 0.8 to 5 times (preferably 1.5 times) the number of moles of the haloketone.
0-2.皓) to use.
溶媒としては、クロロホルム、テトラヒドロフラン、ア
セトン、メチルエチルケトン、メタノール、エタノール
、ジメチルホルムアミド、ジメチルスルホキシド、ヘキ
サメチルトリホスホルアミド、メチルピロリドン等が挙
げられ、ハロケトンに対し重量で1〜100倍(好まし
くは5〜5皓)用いる。Examples of the solvent include chloroform, tetrahydrofuran, acetone, methyl ethyl ketone, methanol, ethanol, dimethylformamide, dimethyl sulfoxide, hexamethyltriphosphoramide, methylpyrrolidone, etc., and the amount is 1 to 100 times (preferably 5 to 5 times) the weight of the haloketone.皓) to use.
反応温度は−10〜100゜C(好ましくは0〜50℃
)、反応時間は1吟〜48時間(好ましくは30分〜2
@間)である。The reaction temperature is -10 to 100°C (preferably 0 to 50°C)
), the reaction time is 1 to 48 hours (preferably 30 minutes to 2 hours).
@ between).
このようにして得られるアジド化合物は、抽出、晶出、
場合によつてはクロマトグラフィーを.用いて単離、精
製してから、あるいは精製せず、溶媒を留去するたけで
つぎの反応に供することができる。The azide compound obtained in this way can be extracted, crystallized,
In some cases, chromatography. It can be subjected to the next reaction after being isolated and purified using the same method, or simply by distilling off the solvent without purification.
かくして得られれるアジド化合物(V)から、還元によ
り直接またはアミノケトン(■)を経由・して、アミノ
アルコール(1)を得ることができる。From the azide compound (V) thus obtained, aminoalcohol (1) can be obtained directly by reduction or via aminoketone (■).
2) アミノケトン(■)の合成
化合物(V)のカルボニル基を残し、アジド基のみを還
元する方法としては、例えば塩化第一スズ/塩化水素、
亜鉛と酢酸、ハロゲン化水素等を7用いる方法がある。2) Synthesis of aminoketone (■) As a method for reducing only the azide group while leaving the carbonyl group of compound (V), for example, stannous chloride/hydrogen chloride,
There are 7 methods using zinc, acetic acid, hydrogen halide, etc.
塩化第一スズ/塩化水素を用いる場合、アジドに対しモ
ル数で1〜5@(好ましくは2〜1皓)量の塩化第一ス
ズを塩化水素て飽和した酢酸と混合して、予め還元剤を
調製しておく。この場合、)用いる酢酸の量は塩化スズ
に対し、重量で2〜20@(好ましくは5〜10皓)で
ある。この還元剤にアジド化合物を添加し、反応時間5
分〜1時間(好ましくは1吟〜1時間)、反応温度−2
0〜100℃(好ましくはO〜50℃)で還元反応を行
な・う。亜鉛と酢酸とを用いる場合、亜鉛をアジド化合
物に対し、モル数で1〜10皓(好ましくは10〜5皓
)用い、溶媒として例えば水、メタノール、エタノール
、酢酸等を重量でアジド化合物の2〜20皓(好ましく
は5〜10@)用いて還元を行なう。When using stannous chloride/hydrogen chloride, stannous chloride in an amount of 1 to 5 (preferably 2 to 1 molar) based on the azide is mixed with acetic acid saturated with hydrogen chloride, and the reducing agent is preliminarily mixed with the acetic acid. Prepare in advance. In this case, the amount of acetic acid used is 2 to 20 (preferably 5 to 10) by weight based on tin chloride. An azide compound was added to this reducing agent, and the reaction time was 5.
minutes to 1 hour (preferably 1 gin to 1 hour), reaction temperature -2
The reduction reaction is carried out at 0 to 100°C (preferably 0 to 50°C). When using zinc and acetic acid, use 1 to 10 moles (preferably 10 to 5 moles) of zinc per mole of the azide compound, and use water, methanol, ethanol, acetic acid, etc. as a solvent, such as water, methanol, ethanol, acetic acid, etc. The reduction is carried out using ~20 ml (preferably 5 to 10 ml).
反応時間は5分〜2肴間(好ましくは1〜10時間)、
反応温度は−20〜50℃(好ましくは0〜30)C)
である。臭化水素、ヨウ化水素等のハロゲン化水素を用
いる場合、ハロゲン化水素はアジド化合物に対し、モル
数で2〜5皓(好ましくは3〜1皓)用いる。Reaction time is 5 minutes to 2 servings (preferably 1 to 10 hours),
The reaction temperature is -20 to 50°C (preferably 0 to 30°C)
It is. When using a hydrogen halide such as hydrogen bromide or hydrogen iodide, the hydrogen halide is used in an amount of 2 to 5 moles (preferably 3 to 1 mole) relative to the azide compound.
溶媒としては水、メタノール、エタノール、酢酸等を重
量でアジド化合物の2〜200倍(好ましくは5〜10
皓)用いる。この還元は、通常は予め溶媒にハロゲン化
水素を溶解しておきそこへアジド化合物を添加して行な
う。反応時間は5分〜4時間(好ましくは10分〜24
時間)てあり、反応温度−10〜1000C(好ましく
はO〜30℃)である。3) アミノアルコール(1)
の合成
アミノアルコール(1)は、前に記載した工程図に示す
ように、アミノケトン(■)を還元する方法及びアジド
化合物(■)を還元する方法により得られる。As a solvent, water, methanol, ethanol, acetic acid, etc. are used in an amount of 2 to 200 times (preferably 5 to 10 times) the weight of the azide compound.
皓) to use. This reduction is usually carried out by dissolving hydrogen halide in a solvent in advance and adding the azide compound thereto. Reaction time is 5 minutes to 4 hours (preferably 10 minutes to 24 hours)
time) and the reaction temperature is -10 to 1000C (preferably 0 to 30C). 3) Amino alcohol (1)
Synthetic amino alcohol (1) can be obtained by the method of reducing the aminoketone (■) and the method of reducing the azide compound (■), as shown in the process diagram described above.
アミノケトン(■)を還元する方法は常法により行なう
ことができる。The aminoketone (■) can be reduced by a conventional method.
A還元剤を使用する方法
還元剤としては、水素化ホウ素ナトリウム、水素化ホウ
素リチウム、水素化ホウ素カリウム、水素化アルミニウ
ムリチウム、水素化リチウムのようなアルカリ金属水素
化物を使用する。A method using a reducing agent As the reducing agent, an alkali metal hydride such as sodium borohydride, lithium borohydride, potassium borohydride, lithium aluminum hydride, and lithium hydride is used.
これらは夫々を単独に、あるいは相互に組合わせて用い
ることもできるし、また水素化ホウ素ナトリウムとルイ
ス酸(塩化アルミニウム、フッ化ホウ素等)との複合体
として用いることもできる。水素化アルミニウムリチウ
ムを用いる場合は、アミノケトン(■)に対し、モル数
ぜ0.2〜5倍(好ましくは0.5〜1ゐ倍)用い、水
素化リチウムを用いる場合は、アミノケトン(■)に対
し、モール数て0.8〜20倍(好ましくは2〜5倍)
用いる。These can be used individually or in combination with each other, or as a complex of sodium borohydride and a Lewis acid (aluminum chloride, boron fluoride, etc.). When using lithium aluminum hydride, the number of moles is 0.2 to 5 times (preferably 0.5 to 1 times) the aminoketone (■), and when using lithium hydride, the aminoketone (■) is used. The number of malls is 0.8 to 20 times (preferably 2 to 5 times)
use
好適な溶媒としてはジエチルエーテル、テトラヒドロフ
ラン、ジオキサン、ジイソプロピルエーテル、ジブチル
エーテル等のエーテル類が用いられる。Suitable solvents include ethers such as diethyl ether, tetrahydrofuran, dioxane, diisopropyl ether, and dibutyl ether.
水素化ホウ素ナトリウム、水素化ホウ素リチウム、水素
化ホウ素カリウム、水素化ホウ素ナトリウムとルイス類
との複合体を用いる場合は、アミノケトン(■)に対し
、モル数で0.5〜5@(好ましくは0.75〜5倍)
を用いる。When using sodium borohydride, lithium borohydride, potassium borohydride, or a complex of sodium borohydride and Lewis compounds, the number of moles is 0.5 to 5 (preferably 0.75 to 5 times)
Use.
好適な溶媒としては水、メタノール、エタノール、プロ
パノール、ブタノール等のアルコール、ピリジン等が用
いられる。上記の還元反応はアミノケトン(■)に対し
て、重量で2〜50皓(好ましくは10〜10@)の溶
媒中で、反応温度−50〜100℃(好ましくは0〜8
0℃)で、反応時間5分〜北時間(好ましくは10〜2
@間)で行なう。Suitable solvents include water, alcohols such as methanol, ethanol, propanol and butanol, and pyridine. The above reduction reaction is performed on the aminoketone (■) in a solvent with a weight of 2 to 50 cm (preferably 10 to 10 @) at a reaction temperature of -50 to 100°C (preferably 0 to 8 °C).
0℃), reaction time 5 minutes to North time (preferably 10 to 2 hours)
@ between).
B接触還元法
例えばパラジウム、ラネーエツケル、酸化白金、ルテニ
ウム等の金属触媒をそのまま、あるいは炭素、硫酸バリ
ウム等に担持した触媒の存在下に水素添加を行なう。B Catalytic Reduction Method Hydrogenation is carried out using a metal catalyst such as palladium, Raney-Etzkel, platinum oxide, or ruthenium as it is or in the presence of a catalyst supported on carbon, barium sulfate, or the like.
触媒量はアミノケトン(■)に対し、重量で0.01〜
1皓(好ましくは0.05〜1倍)を用いる。The amount of catalyst is from 0.01 to aminoketone (■) by weight.
1x (preferably 0.05 to 1x) is used.
好適な溶媒としては水、メタノール、エタノール等のア
ルコール、ジオキサン、テトラヒドロフラン等のエーテ
ル、酢酸等が挙げられ、アミノケトン(■)に対し、重
量で5〜50皓(好ましくは10〜10皓)用いる。反
応温度は0〜150′C(好ましくは20〜80℃)、
反応時間は1〜北時間(好ましくは2〜2@間)である
。アジド化合物(V)の還元は前述の水素化アルミニウ
ムリチウムあるいは水素化リチウムを用いる場合に準じ
て行なうことができる。Suitable solvents include water, alcohols such as methanol and ethanol, ethers such as dioxane and tetrahydrofuran, acetic acid, etc., and are used in an amount of 5 to 50 (preferably 10 to 10) by weight per aminoketone (■). The reaction temperature is 0 to 150'C (preferably 20 to 80C),
The reaction time is between 1 and 1 hour (preferably between 2 and 2 hours). The reduction of the azide compound (V) can be carried out in the same manner as described above using lithium aluminum hydride or lithium hydride.
以下に本発明を参考例・実施例により更に、詳細に説明
する。The present invention will be explained in more detail below using reference examples and examples.
参考例1
1−(4−イソプロピチルチオフエニル)−2−アミノ
プロパノンの合成1−(4−イソプロピルチオフェニル
)−2−プロムプロパノン2.52g(10mm01)
をジメチルスルホキシド10Tntに溶解し、攪拌しつ
つ、ナトリウムアジド0.98g(15rnm01)を
徐々に添加した。Reference Example 1 Synthesis of 1-(4-isopropylthiophenyl)-2-aminopropanone 1-(4-isopropylthiophenyl)-2-prompropanone 2.52g (10mm01)
was dissolved in 10 Tnt of dimethyl sulfoxide, and while stirring, 0.98 g (15 rm01) of sodium azide was gradually added.
室温で2時間攪拌を続けた後、50mLの水を添加し、
20m1のベンゼンで3回抽出した。有機層を硫酸マグ
ネシウムで乾燥した後、ベンゼンを留去して、淡黄色の
半個体状物質2.0gを得た。この物質を、さらに精製
することなく、そのままの形で赤外吸収スペクトル、核
磁気共鳴スプクトルを測定し、1−(4−イソプロピル
チオフェニル)−2−アジドプロパノンであることを確
認した。別途、塩化第一スズ2水塩4.5g(20rT
1m01)と無水酢酸4mtとを還流温度で1紛間加熱
した後8m1の氷酢酸を加え、そこに、塩化水素を飽和
して還元剤を調製した。After continued stirring at room temperature for 2 hours, 50 mL of water was added,
Extracted three times with 20 ml of benzene. After drying the organic layer with magnesium sulfate, benzene was distilled off to obtain 2.0 g of a pale yellow semi-solid substance. This substance was subjected to infrared absorption spectrum and nuclear magnetic resonance spectroscopy without further purification, and was confirmed to be 1-(4-isopropylthiophenyl)-2-azidopropanone. Separately, 4.5 g of stannous chloride dihydrate (20rT
After heating 1 m01) and 4 mt of acetic anhydride at reflux temperature, 8 m1 of glacial acetic acid was added thereto, and the mixture was saturated with hydrogen chloride to prepare a reducing agent.
この還元剤を氷冷し、1−(4−イソプロピル、チオフ
ェニル)−2−アジドプロパノン1.25g(5mm0
1)と氷酢酸2m1からなる溶液を攪拌きつつ添加した
。This reducing agent was cooled on ice, and 1.25 g of 1-(4-isopropyl, thiophenyl)-2-azidopropanone (5 mm 0
A solution consisting of 1) and 2 ml of glacial acetic acid was added with stirring.
1紛間攪拌を続けたのち、減圧で酢酸を留去し、10%
カセイソーダ20m1を加え、工ーテル50m1で抽出
し、ただちに塩化水素を通じ、析ノ出した結晶を淵取し
た。1 After continuing to stir the powder, acetic acid was distilled off under reduced pressure, and 10%
20 ml of caustic soda was added and extracted with 50 ml of ether, hydrogen chloride was immediately passed through the mixture, and the precipitated crystals were filtered out.
収量0.72g(収率55%)、Mp.l8O〜188
゜C(分解)。この化合物は赤外吸収スペクトル及び核
磁気共鳴スペクトルにより、1一(4−イソプロピルチ
オフェニル)−2−アミノプロパノン・塩酸塩であるこ
とを確認した。参考例21−(4−イソプロピルチオフ
ェニル)−2−アミノプo/マノールの合成上記参考例
1で得たアミノケトン(・塩酸塩522m9(2111
m0りをメタノール10mtに溶解し、水素化ホウ素ナ
トリウム200m9加えて、室温で2時間攪拌した。Yield 0.72g (yield 55%), Mp. l8O~188
°C (decomposition). This compound was confirmed to be 1-(4-isopropylthiophenyl)-2-aminopropanone hydrochloride by infrared absorption spectrum and nuclear magnetic resonance spectrum. Reference Example 2 Synthesis of 1-(4-isopropylthiophenyl)-2-aminopo/manol
ml was dissolved in 10 mt of methanol, 200 m9 of sodium borohydride was added, and the mixture was stirred at room temperature for 2 hours.
メタノールを留去した後水10m1を加え、クロロホル
ムで抽出した。硫酸マグネシウムで乾燥し、クロロホル
ムを留去して360Tn9の結晶を得た。(収率80%
)、Mp.lOO〜101℃。生成物は赤外吸収スペク
トル及び核磁気共鳴スペクトルにより、1−(4−イソ
プロピルチオフェニル)−2−アミノプロパノールであ
ることを確認した。実施例1参考例2において得られた
アミノアルコール1.12g(MmOl)と臭化オクチ
ル1.0g(5.5n1m0I)とをエタノール50m
1中で2日間還流した。After methanol was distilled off, 10 ml of water was added and extracted with chloroform. It was dried over magnesium sulfate and chloroform was distilled off to obtain crystals of 360Tn9. (yield 80%
), Mp. lOO~101°C. The product was confirmed to be 1-(4-isopropylthiophenyl)-2-aminopropanol by infrared absorption spectrum and nuclear magnetic resonance spectrum. Example 1 1.12g (MmOl) of the amino alcohol obtained in Reference Example 2 and 1.0g (5.5n1m0I) of octyl bromide were mixed in 50ml of ethanol.
The mixture was refluxed in 1 for 2 days.
反応終了後、エタノールを留去すると結晶が析出した。
水及びエーテルで洗い、乾燥して臭化水素酸塩1.3g
(収率69.5%)の結晶を得た。この結晶0.5gを
、カセイカリ94mgのメタノール5m1溶液に溶解し
、そこへ水10mtを加え、冷所に放置して結晶を析出
させ、更にn−ペンタンで再結晶した。Mp.6l〜6
3℃。特開昭49−135935号公報記載の方法で合
成した生成物を標品としての混融試験及び赤外吸収スペ
クトルの比較により、この結晶が目的の1−(4−イソ
プロピチルチオフエニル)−2−n−オクチルアミノプ
ロパノール(工リトロ体)であることを確認した。実施
例2
参考例2のようにして得たアミノアルコール1.12g
(5rnm01)とp−トルエンスルホン酸オクチル1
.42g(5n1m01)とをベンゼン10m1中で2
4時間還流した。After the reaction was completed, ethanol was distilled off and crystals were precipitated.
Wash with water and ether, dry and hydrobromide 1.3g
(Yield 69.5%) crystals were obtained. 0.5 g of this crystal was dissolved in a solution of 94 mg of caustic potash in 5 ml of methanol, 10 mt of water was added thereto, and the mixture was left in a cold place to precipitate crystals, which was further recrystallized from n-pentane. Mp. 6l~6
3℃. A mixing test using the product synthesized by the method described in JP-A-49-135935 as a standard and comparison of infrared absorption spectra revealed that this crystal was the desired 1-(4-isopropylthiophenyl)- It was confirmed that it was 2-n-octylaminopropanol (retroform). Example 2 1.12 g of amino alcohol obtained as in Reference Example 2
(5rnm01) and octyl p-toluenesulfonate 1
.. 42g (5n1m01) in 10ml of benzene
It was refluxed for 4 hours.
Claims (1)
−アミノプロバノールもしくはその塩と式CH_3(C
H_2)_6CH_2X(式中、Xはハロゲン原子又は
酸のエステル残基を表わす。 )で示される化合物とを反応させることを特徴とする式 ▲数式、化学式、表等があります▼ で示される1−(4−イソプロピルチオフェニル)−2
−n−オクチルアミノプロパノールもしくはその塩の製
造法。[Claims] 1 1-(4-isopropylthiophenyl)-2 represented by the formula ▲There are mathematical formulas, chemical formulas, tables, etc.▼
-Aminoprobanol or its salt and formula CH_3(C
H_2) _6CH_2X (wherein, (4-isopropylthiophenyl)-2
- A method for producing n-octylaminopropanol or a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7078577A JPS6046110B2 (en) | 1977-06-15 | 1977-06-15 | Method for producing 1-(4-isopropylthiophenyl)-2-n-octylaminopropanol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7078577A JPS6046110B2 (en) | 1977-06-15 | 1977-06-15 | Method for producing 1-(4-isopropylthiophenyl)-2-n-octylaminopropanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS545930A JPS545930A (en) | 1979-01-17 |
| JPS6046110B2 true JPS6046110B2 (en) | 1985-10-14 |
Family
ID=13441517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7078577A Expired JPS6046110B2 (en) | 1977-06-15 | 1977-06-15 | Method for producing 1-(4-isopropylthiophenyl)-2-n-octylaminopropanol |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6046110B2 (en) |
-
1977
- 1977-06-15 JP JP7078577A patent/JPS6046110B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS545930A (en) | 1979-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4146638A (en) | N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines | |
| JPH03503163A (en) | New amines, their uses and manufacturing methods | |
| RU2213743C2 (en) | Derivative of thienylazolylalkoxyethaneamine, method for its preparing (variants), pharmaceutical composition, intermediate compound and method for its preparing (variants) | |
| HK1006021B (en) | 4h-1-benzopyran-4-one derivatives, process for their preparation and their use as medicaments | |
| HK1006021A1 (en) | 4h-1-benzopyran-4-one derivatives, process for their preparation and their use as medicaments | |
| JP2003513062A (en) | Polymorphic forms of sertraline hydrochloride | |
| JPS5912113B2 (en) | Process for producing ethanolamine derivatives or acid addition salts thereof | |
| JPS6026782B2 (en) | Method for producing novel arylpiperidine derivatives | |
| JPH0687798A (en) | Method of producing new phenylpropinylamine derivative | |
| JPH0153267B2 (en) | ||
| EP0187700B1 (en) | Novel aminoalkyl substituted urea derivatives, acid addition salts thereof and enatiomers | |
| BRPI0806411B1 (en) | process for the preparation of a compound and compounds | |
| JPS5913510B2 (en) | Calbostyril Yudou Tainoseizohou | |
| JP3213324B2 (en) | Novel N-benzoylmethyl-piperidines | |
| HUE033534T2 (en) | Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide | |
| JPS5826332B2 (en) | Tetralolka Gobutsu no Seizouhou | |
| US2431285A (en) | Process for preparing 1-(dihydroxy-phenyl)-2-amino butanol-1 and intermediates | |
| JPS5950671B2 (en) | Phenylethanolamine derivative and method for producing the same | |
| JPS6046110B2 (en) | Method for producing 1-(4-isopropylthiophenyl)-2-n-octylaminopropanol | |
| JPS6046109B2 (en) | 1-(4-isopropylthiophenyl)-2-n-octanoylaminopropane derivative and method for producing the same | |
| JPS6026780B2 (en) | 1-(4-isopropylthiophenyl)-2-aminopropane derivative and method for producing the same | |
| US4021558A (en) | 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents | |
| KR880001298B1 (en) | Preparation of benzoyl-phenyl-piperidine derivatives | |
| IL43726A (en) | 1-phenoxy-3-(p-carbamoylphenoxy)ethylamino-2-propanol derivatives and pharmaceutical compositions containing them | |
| US3093652A (en) | Alkyl 1-(2-aryl-2-oxoalkyl)-4-phenylpiperidine-4-carboxylates and their preparation |